Radiation-Activated Antitumor Vectors

作者: Simon D. Scott , Brian Marples

DOI: 10.1385/1-59259-429-8:389

关键词: RefractoryIonizing radiationMedicineRadiationChemotherapyPathologyCancer researchVectors in gene therapyRadiation therapyGenetic enhancementDNA damage

摘要: Radiotherapy (RT) is a primary treatment modality for the majority of solid tumors. The objective to destroy tumor mass by exposure ionizing radiation (IR) from an external beam or isotopic source. IR causes DNA damage directly and indirectly via production reactive oxygen intermediates (ROIs). Accumulation sufficient leads cell death. efficacy RT usually governed dose given, main limitation being need avoid injury surrounding normal tissues. To address latter problem, physical techniques such as conformal intensity-modulated radiotherapy have been developed improve precision delivery volume. However, some tumors prove refractory conventional treatments, insufficient can be delivered tumor. In cases, other therapeutic strategies, chemotherapy, used in combination, particularly if drugs lead increased radiosensitization. Nevertheless, many types, (e.g., glioblastoma) are often resistant even these combined approaches. Consequently, there new strategies that effectiveness current regimens. Gene therapy offers exciting possibility significantly improving without IR-dose escalation undue increases tissue morbidity. Furthermore, potential spatially temporally target activation gene vectors using clinically relevant doses provides attractive prospect.

参考文章(19)
C H Tsai-Morris, V P Sukhatme, R G Hoover, S Kartha, F G Toback, R Taub, A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. oncogene Research. ,vol. 1, pp. 343- 355 ,(1987)
J C Gasson, K E Yates, M A Raines, C Bardeleben, D W Golde, K M Sakamoto, 5' upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8. Oncogene. ,vol. 6, pp. 867- 871 ,(1991)
David A. Boothman, Edward N. Hughes, Isabelle Bouvard, Identification and Characterization of X-Ray-induced Proteins in Human Cells Cancer Research. ,vol. 49, pp. 2871- 2878 ,(1989)
D Gius, X M Cao, F J Rauscher, D R Cohen, T Curran, V P Sukhatme, Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene expression via CArG elements. Molecular and Cellular Biology. ,vol. 10, pp. 4243- 4255 ,(1990) , 10.1128/MCB.10.8.4243
Michael B. Kastan, Qimin Zhan, Wafik S. El-Deiry, France Carrier, Tyler Jacks, William V. Walsh, Beverly S. Plunkett, Bert Vogelstein, Albert J. Fornace, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia Cell. ,vol. 71, pp. 587- 597 ,(1992) , 10.1016/0092-8674(92)90593-2
B. Christy, D. Nathans, DNA binding site of the growth factor-inducible protein Zif268. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 8737- 8741 ,(1989) , 10.1073/PNAS.86.22.8737
SD Scott, B Marples, JH Hendry, LS Lashford, MJ Embleton, RD Hunter, A Howell, GP Margison, A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Therapy. ,vol. 7, pp. 1121- 1125 ,(2000) , 10.1038/SJ.GT.3301223
Wafik S El-Deiry, Takashi Tokino, Victor E Velculescu, Daniel B Levy, Ramon Parsons, Jeffrey M Trent, David Lin, W Edward Mercer, Kenneth W Kinzler, Bert Vogelstein, WAF1, a potential mediator of p53 tumor suppression Cell. ,vol. 75, pp. 817- 825 ,(1993) , 10.1016/0092-8674(93)90500-P
Sally A. Amundson, Khanh T. Do, Albert J. Fornace, Induction of stress genes by low doses of gamma rays. Radiation Research. ,vol. 152, pp. 225- 231 ,(1999) , 10.2307/3580321